Erenumab is a whole-human monoclonal antibody. Erenumab inhibits calcitonin gene-related peptide (CGRP) receptors. Erenumab can be used to prevent migraine attacks.
Purity:
>95%
CAS Number:
[1582205-90-0]
Target:
CGRP Receptor
* VAT and and shipping costs not included. Errors and price changes excepted